Kinase signaling in liver disease via clinical-trial-on-a-PamChip: A distinctive methodology for drug mechanisms and personalized medicine
Z
Zachary A. Kipp
E
Evelyn A. Bates
G
Genesee J. Martinez
W
Wang-Hsin Lee
S
Sally N. Pauss
T
Terry D. Hinds
Article Details
Journal
Journal of Biological Chemistry
Volume / Issue
Vol. 302, Issue 5
Published
May 01, 2026
Pages
111379
ISSN
0021-9258
Publisher
Elsevier BV
Authors (6)
Z
Zachary A. Kipp
E
Evelyn A. Bates
G
Genesee J. Martinez
W
Wang-Hsin Lee
S
Sally N. Pauss
T
Terry D. Hinds
Related Articles from this Journal
Asialoglycoprotein receptor subunit Asgr1a loss results in attenuated cholesterol absorption in zebrafish fed a western diet
Joshua T. Derrick, Tabea O.C. Moll et al.
Aug 2026
10.1016/j.jbc.2026.113239
Nrf2-mediated epigenetic priming of osmoprotective genes enhances cellular adaptation to hyperosmotic stress
Yi Lu, Na Li et al.
Aug 2026
10.1016/j.jbc.2026.113278
Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function
Kailash Venkatraman, Daniel Milshteyn et al.
Aug 2026
10.1016/j.jbc.2026.113306
Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression
Katerina-Marina Pilala, Artemis-Melina Papadimitriou et al.
Aug 2026
10.1016/j.jbc.2026.113302
Correction: Abstract 5588 Multifunctional carbon dots nanocarriers: Dual-drug delivery via π-π stacking interaction for stimuli-responsive chemotherapy and high oxidative stress
Girum Demissie, Jia Chang
Aug 2026
10.1016/j.jbc.2026.113253